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The variable or V  regions of the Ig heavy chains have invariable, variable, 
and hypervariable sections  (1,  2). The individual antigenic specificities or idi- 
otypes (3, 4) have their localization in the hypervariable regions or near these 
regions (5). In the relatively invariant sections there are certain positions in the 
amino acid sequence,  which permit the  classification  of the heavy  chains of 
different myeloma proteins into three main heavy-chain variable region  (V~) 
subgroups. However, because of the difficulties in sequencing multiple proteins, 
only limited data are available on the incidence and distribution of these three 
different types. The aim of the present study was to establish serological typing 
systems for the determination of VH subgroups in myeloma proteins and in the 
Ig of normal sera.  Such a system would have many advantages in addition to 
procedural simplification; characterization of the membrane Igs of lymphocytes 
would be a specific example. The typing systems developed in this study utilized 
antisera made against myeloma proteins with known Vn subgroups as deter- 
mined by amino acid sequence analysis. Certain of these antisera after absorp- 
tion could be made specific for each of the three subgroups. 
Materials and Methods 
Myeloma Proteins.  Myeloma proteins with known amino acid sequence of the V region of the 
heavy chain were from our own laboratories or received from other sources. Some of the myeloma 
proteins used were kindly provided by Doctors H.  Bennich,  D.  Capra,  M.  Fougereau,  and  F. 
Putman. The proteins with known VH subgroup based on amino acid sequence are given in Table 
II; many of these have been previously described (2, 6-10). A number of other proteins had only 
been partially  typed  by  testing for blocked or  unblocked  N-terminal residues  (11) or  with  a 
recently developed chemical typing system based on peptide analysis  (12). In addition, a large 
number of myeloma proteins with known Ig class,  subclass,  and  light-chain type but without 
known VH subgroup were tested. 
Myeloma proteins were initially isolated from the whole sera by starch block electrophoresis 
(13, 14) or by DEAE-cellulose (Whatman DE-52) column chromatography in 0.015 M phosphate 
buffer, pH 7.6 (14--16). In other cases the myeloma proteins were eluted from a DEAE-cellulose 
column by a  gradient from 0.015 M to 0.3 M phosphate  buffer, pH 7.6. The myeloma proteins 
obtained were finally gel filtrated on a Sephadex G150 column under neutral conditions to give the 
IgG, IgA, IgM, IgD, or IgE proteins used. The purity of the various fractions of myeloma proteins 
were tested by agarose gel electrophoresis aider the DEAE-cellulose and G150 steps. 
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Antisera.  Antisera against whole myeloma proteins,  F(ab')2,  and Fc fragments of myeloma 
proteins as well as light chains from pooled T-globulin were raised in rabbits (15). In addition, the 
anti-VH  subgroup  antisera  were  raised  primarily  in  rabbits  by  immunization  with  myeloma 
proteins of known Vn subgroup according to amino acid sequence analysis. One anti-VHII antise- 
rum  (anti-Cor)  was raised  in a  baboon.  Before use,  the antisera were absorbed  to make them 
subgroup specific and to eliminate all the antibodies against the constant part of the heavy chains 
and the antibodies against the light chains.  For example, anti-V, II was absorbed with VHI and 
VHIII proteins (2-3 mg/ml), as well as 1-2 mg/ml of light chains. In addition, one of the myeloma 
proteins used in absorption was selected to have the same Ig constant region class and subclass as 
the myeloma proteins used for immunization.  Thus all antibody activities except those directed 
against the V. subgroup-specific antigens and idiotypes were presumably eliminated. For each VH 
subgroup  at least two different antisera were available, one made against  a  K-protein and one 
against a ~-protein. In working with these anti-VH-subgroup antisera in hemagglutination experi- 
ments, the myeloma proteins used for coating of red cells were always different in K or ~. from those 
used for immunization. 
Enzymatic Fragmentation and Isolation of Heavy and Light Chains of  lgG.  F(ab')~ fragments 
of IgG were prepared  by pepsin  digestion at  an  enzyme to substrate  ratio of 2:100  (wt/wt)  as 
described earlier (15).  To isolate heavy and light chains, IgG was first reduced by dithiothreitol 
and  subsequently  alkylated.  Then  it  was  gel  filtered  under  dissociating  conditions  in  5  M 
guanidine-1 M acetic acid on a Sephadex G-100 column to isolate heavy and light chains (11). The 
purity was controlled in hemagglutination-inhibition tests and double-diffusion tests as described 
before (15). 
Hemagglutination Inhibition Tests.  These tests were carried out with O red cells coupled by 
the chromic chloride method to isolated myeloma proteins of known VH subgroup (17). The coated 
red cells were washed four times in sterile 0.9% saline.  From a  stock solution of 50 mg chromic 
chloride (× 6 H20) in 5 ml 0.9% NaC1, 0.05 ml were diluted in 0.45 ml of 0.9% NaC1. Then 0.05 ml of 
the last mixture was added to an equal amount of packed red cells, the tube was shaken for 1 min, 
and 0.1 ml of myeloma proteins (2 mg/ml) was added. The mixture was left at room temperature 
for 4-5 min, the coated cells washed four times with 20-40 volumes excess of saline, and used as a 
1% suspension within 24 h in hemagglutination and inhibition tests as described in detail before 
(16-18). 
Results 
Specific Antisera  Detecting VH Subgroups,  and Relationship  between VH 
Subgroups Determined Serologically and by Sequence Analysis.  The anti-Vu- 
subgroup antisera  prepared and  absorbed  as  described  above did not show 
precipitating  activity  in  double-immunodiffusion experiments.  They  were, 
therefore,  tested  in hemagglutination and hemagglutination-inhibition tests 
(Tables I and II). For this purpose red cells were coated with another myeloma 
protein than the one used for immunization but carrying the same VH-subgroup 
specificity. In this way idiotypic-specific reactions were avoided. In selecting 
proteins for red cell coating only those were used with a different light-chain 
type than the protein used for immunization, thus avoiding reactions related to 
heavy-chain interactions with n-chains which are seen for the CNI=region anti- 
gens of IgA and several IgG subclasses (19, 20). Using such procedures, specific 
agglutination was obtained for each of the three VH-subgroup antisera with 
titers of 64-128  when tested against red cells coated by proteins carrying the 
corresponding VH subgroup (Table I). In contrast, no cross-reactions between the 
different thoroughly absorbed VH-subgroup antisera were observed. 
The specificities of the serological VH-subgroup reactions were further tested 
in hemagglutination-inhibition experiments. Thus myeloma proteins with a VH 
subgroup defined by amino acid sequence analysis only inhibited in systems 
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TABLE  I 
Titers of Anti-Ig and Specifically Absorbed Anti-V, Subgroup Antisera Against Red 
Cells Coated by Myeloma Proteins with Chemically Defined VH Subgroup 
Anti-  Anti-  Anti- 
Proteins used for red cell coating  Anti-Ig (R:115)  VHI(ND)*  VHII(Lev)*  V.III(Jon)* 
(R:346)  (R: 161)  (R:349) 
Ste  VHI (IgG1-K)  4,000  128  <2  <2 
Ou  VHII (IgM-K)  2,000  <2  64  <2 
Tei  VHIII (IgG1-K)  2,000  <2  2  64 
In all systems idiotypic reactions were avoided since different proteins were used for coating and 
for immunization. Controls: no agglutination of unsensitized red cells or of coated red cells in 
PBS. 
* The ND protein is VHI, IgE-X,  Lev is VHII, IgG3-~,,  and Jon is V.III, IgG3-~,. 
TABLE  II 
Inhibition  of Serological V~ Subgroup Systems by Myeloma Proteins of Chemically 
Determined V. Subgroup as well as Ig Chains and Fragments 
Test systems using red cells coated by myeloma protein: 
V.I Stu and anti-  V.II Ou and  VHIII Tei and anti- 
VHI*  anti-VHH*  VHIII* 
VnI myeloma proteins 
ND  IgE-~,  0.0025  - 
Stu  IgG1-K  0.001  - 
Hus  IgG3-K  0.004  - 
VHII myeloma proteins 
Cor  T1-K  --  0.002 
Ou  IgM-K  -  0.002 
Lan  IgA2-K  -  0.002 
Lev  IgG3-~  -  0.008 
Herin  IgG3-k  -  0.004 
VHIII myeloma proteins 
Jon  IgG3-~,  -  - 
Falk  IgG1-K  -  - 
Tei  IgG1-K  -  - 
Sho  IgAl-~  -  - 
Nie  IgGl-g  -  - 
Dau§  IgM  -  - 
Ig chains and fragments 
Gamma KABI  0.03  0.008 
Heavy chain  0.03  0.004 
Light chain  -  - 












* Antisera are the same as in Table I. 
$ Lowest concentration (mg/ml) giving inhibition. -,  No inhibition at starting dilution of 0.5 mg/ 
ml. 
§ This protein has certain sequence characteristics of VHIII subgroup proteins, although initially 
thought to be in a  new VH subgroup (1). 
belonging  to  a  given  VH  subgroup  inhibited  equally  well,  the  systems  were 
clearly  not  dependent  on  K  and  ~  light-chain  determinants.  Furthermore,  no 
relation  was  seen  to constant  heavy-chain  determinants  such  as Ig classes  and 
subclasses.  Also,  isolated  heavy  chains  but  not  light  chains  inhibited  the  anti- 900  DETECTION  OF  VARIABLE  REGION  SUBGROUPS  OF  Ig  HEAVY  CHAINS 
V. antisera. Pooled IgG and F(ab')2 fragments showed inhibition in all the VH 
systems (Table II), although somewhat weaker for the V.I system. The results 
obtained by the serological vs. the sequence method showed a striking correla- 
tion. The only possible exception was with the protein Dau which by amino acid 
sequence analysis was thought to be either VnIII or a new subgroup (1); it gave a 
strong inhibition in the V.III system and therefore serologically appeared to be 
subgroup VHIII. 
Distribution  of Serologically Determined  Subgroups in Proteins which had 
been Partially  Chemically  Classified  by Studying Blocked  or  Unblocked  N 
Terminus or by Peptide Analysis.  Two other techniques have been applied for 
chemical determination of V.  subgroups.  One  is  to  determine whether the 
proteins are blocked or unblocked (11), since almost all V.I and V.II proteins 
have blocked N  terminus, while V.III proteins usually are unblocked. Seven 
proteins which had been previously determined by this chemical method were 
studied in the serological V~ typing system. Four were V.II and three were 
V.III. All the proteins with blocked N terminus were VHII, and the unblocked 
were VHIII. 
Comparisons were also made with the results of a  new and only partially 
defined typing system employing tryptic and chymotryptic peptides (12). Nine 
proteins which had been determined by this technique were studied. Eight of 
them showed concordant results. However, one protein which was considered as 
VHIII by the chemical peptide analysis was VHII by the serological test. This 
particular protein was repeatedly tested as V.II in different serological test 
systems, while no inhibition was seen in different V.III test systems. 
Distribution  of Serologically Determined VH Subgroups in Myeloma Proteins 
with Unkown VH Subgroup.  A panel of 131 myeloma proteins without previ- 
ously known heavy-chain variable subgroup was then tested in the three VH 
hemagglutination-inhibition test systems. 19 proteins (about 16%) belonged to 
the  V.I  subgroup,  45  (about 33%) to  VHII, and 65  (about  50%) were  VHIII- 
subgroup proteins (Table III). In each of the groups both K- and h-proteins were 
represented. All the proteins except two were typable in one of the three V.- 
subgroup systems and each reacted with only a  single subgroup system. The 
nontypable proteins were IgG3 and IgG4 proteins, respectively. These proteins 
were  clearly  shown to  inhibit IgG3  and  IgG4  subclass test  systems and to 
precipitate with anti-IgG-specific antisera  in double immunodiffusion. These 
two proteins which were not VuI,  V.II,  or V.III by the test systems might 
represent  other  heavy-chain  variable  subgroups  than  the  three  main  VH 
subgroups  described  above,  or  alternatively  rare  genetic  variants  of these 
subgroups. Plans are underway to study these proteins in detail by chemical 
procedures. 
Table III also lists, according to serological typing, all the available proteins 
studied  including the  131  myeloma proteins  with  previously unknown V. 
subgroup and in addition 36 proteins which had been classified by some chemical 
technique. Altogether 167 proteins are thus included and the percentage distri- 
bution of the three V. subgroups within the different Ig classes and subclasses 
are listed in brackets. The percentage distribution in this total material was 
almost the same as in the previously unclassified group and showed VHIII to be 
the  predominant  subgroup,  representing  50%  of the  total  while  the  V.II 0.  FORRE,  J.  B.  NATVIG,  AND  H.  G.  KUNKEL  901 
TABLB  III 
Relation between Classes, Subclasses, and Y H Subgroups in Myeloma Proteins 
According to Serological  VH Typing 
Class 
VHI  VHII  VHIII  Unclassified 
U  T  %  U  T  %  U  T  %  U  T  % 
IgG1  7  12  (18)  22  25*  (37)  23  31  (45) 
IgG2  4  4  (27)  4  4  (27)  7  7  (46) 
IgG3  0  1  (5)  7  9  (47)  7  8  (42)  1  1  (5) 
IgG4  1  1  (11)  1  3  (33)  3  4  (44)  1  1  (11) 
Total IgG  12  18  (16)  34  41  (37)  40  50  (45)  2  2  (2) 
IgA1  1  1  (5)  3  5  (28)  12  12  (67) 
IgA2  1  1  (20)  1  4  (80) 
Total IgA  1  1  (4)  4  6  (26)  13  16  (70) 
IgM  6  7  (24)  7  8  (28)  9  14  (48) 
IgD  2  2  (100) 
IgE  0  1  (50)  1  1  (50) 
Total Ig  19  27  (16)  45  55  (33)  65  83  (50)  2  2  (1) 
U, myeloma proteins with unknown VH subgroup. T, total of myeloma proteins with chemically 
defined  VH  subgroup  and  myeloma proteins  with  unknown  VH  subgroup.  %,  Percentage  of 
classes, subclasses,  and total Ig. 
* One protein in this group was typed as a VMIII by peptide analysis of Moulin et al. (12) but was 
repeatedly VHII by serological testing (see text). 
subgroup comprised 33% and the VHI subgroup about 16% of the total Ig. Thus 
there was an overall ratio of approximately 1:2:3 for VHI:VHII:VHIII. 
The relative distribution of the VH subgroups within the different Ig classes 
and subclasses is also presented. For IgG the distribution was VHI, 16%; VHII, 
37%; and V~IH, 45%. This is nearly the same as for total Ig, but slightly more 
VHII and  slightly less  VHIII. Some  differences from this  distribution  were 
observed in the IgG subclasses. Particularly IgG3 had rather high percentages 
for VHII and IgG2 was rather high for VHI. Further analysis especially of the IgG 
subclasses is required to establish a significant relationship. In the case of IgA 
about 70% of the IgA myeloma proteins belonged to the VHIII subgroup, while 
VHI was low. For the IgM proteins, the distributions were VHI, 24%; VHII, 28%; 
and VHIII, 48% indicating that VHIII again was the major subgroup. The present 
work comprised too few IgD and IgE myeloma proteins to get a representative 
distribution pattern, but the two IgD and the IgE myeloma proteins were all 
found to react in one of the VH-subgroup systems. 
On the basis of the above serological VH-subgroup  determination several of 
the myeloma  proteins not previously studied chemically, along with their specif- 
ically absorbed  antisera,  were tried  as  typing reagents.  In each case these 
proteins could be used as coating reagents and several of the stronger antisera 
could be used as agglutinators furnishing hemagglutination-inhibition  systems, 
similar to the ones described above, to detect the corresponding VH subgroup. 
However, it should be  emphasized that only a  few of the  antisera could be 
utilized as typing reagents. In many instances no subgroup-specific agglutina- 
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Relative Amounts of the VH Subgroups in Different Human Sera.  13 normal 
Caucasian sera including sera from 3 homozygous Gm(a+g+) and 3 homozygous 
Gm(f+b+) individuals, as well as Japanese and Negro sera were iavestigated. 
Semiquantitative  hemagglutination-inhibition  experiments  were  performed 
with the V.-subgroup systems that had similar sensitivity and were inhibited 
by positive myeloma proteins down to a concentration of 0.002-0.008  mg/ml. In 
all  cases there was  less  inhibition  in the VHI system than in  the other test 
systems. The normal sera inhibited in a maximum dilution of 256-512 in the VMI 
system while inhibition was seen in dilutions from 1,024 to 4,096 in the V,II and 
VHIII systems, again with somewhat stronger inhibition in the VHIII system. No 
obvious relationship was observed between the inhibitory capacity in the V.- 
subgroup systems and the population groups with different Gm types. 
Discussion 
Previous studies have indicated that the serological determination of V-region 
subgroups is feasible. This was first carried out on kappa chains by Solomon and 
McLaughlin  (21)  where clear correlation  between the  sequence typing  and 
serological analysis was obtained. These studies were extended and the serologi- 
cal  typing  utilized  for  extensive  studies  on  kappa  chains  in  various  cross- 
idiotypic systems (22). Certain discrepancies were encountered in this survey 
that were probably due in part to ambiguities in the chemical typing analyses. 
Serological sub-subgroups have also been defined in the kappa chain system (22, 
23).  Less work has been done in the lambda system but here too evidence is 
available  that  serological methods can be  used  with results  paralleling  the 
typing by sequence (24). 
Because of the considerable amount of sequence homology in the primary 
structure of  proteins belonging to the same V. subgroups, it was expected that it 
might be possible to establish a serological typing system for the determination 
of VH subgroups.  However, it proved necessary to use selected hyperimmune 
heteroantisera and very careful absorptions to get specific reagents, Additional 
precautions  were  taken  to  avoid  idiotype  antibodies,  antibodies  to  genetic 
markers, and those to light-chain antigens as well as other determinants (20). 
The  specificities of the  VH  test  systems utilized  in  the  present  study were 
established in several ways. Firstly, myeloma proteins chemically defined by 
amino acid sequence to belong to the three major subgroups became the main 
standard of reference. They could be classified into three groups serologically, 
There was complete unambiguous agreement between the sequence and serolog- 
ical typing except possibly in the case of one protein. Here the sequence typing 
was interpreted as a possible new subgroup although it had some characteristics 
of VHIII; serologically it clearly fell into the VHIII category. Secondly, a compari- 
son was made with a preliminary chemical typing procedure using the peptide 
analysis method of Moulin et al.  (12); here there was one difference in nine 
myeloma proteins analyzed. This one exception requires further work to verify 
the chemical typing. Also, seven myeloma proteins tested by Capra and Kehoe 
(11) for blocked or unblocked N  terminus showed concordance with the sero- 
logical  system.  Thirdly,  in  a  group of 167  untyped myeloma proteins exam- 
ined, with only two exceptions, all proteins could be classified into one of the 
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has been possible to show that the same three main serological VH subgroups are 
present in immune antibodies and exhibit in general a considerable restriction 
compared to normal v-globulin (25). 
It was perhaps somewhat surprising that virtually all proteins tested invaria- 
bly were classifiable in one or another of the three VH serological groups. This is 
certainly due in part to the advantage of using hemagglutination-inhibition 
techniques which detect only the main common antigenic features between the 
proteins  in  a  given VH  subgroup.  This  results from the  fact that  only the 
antigenic properties shared by the myeloma proteins used for coating of the red 
cells and the ones used for immunization will be detected (18). In this study 
different coat proteins as well as different antisera gave similar results. How- 
ever, exceptions may be encountered in further studies as in the VK subgroups 
(22). The two nonclassifiable proteins noted in the large scale study described 
above appear likely to represent a fourth subgroup. Preliminary studies with an 
antiserum to one of the proteins supports this conclusion. 
The  proteins  classifiable  according to  the  three serological VH  subgroups 
which included virtually all of the myelomas studied showed an overall ratio of 
approximately 1:2:3 for VHI:V~II:VHIII. Corresponding studies on normal sera by 
semiquantitative titrations, indicated that the normal Ig pool includes the same 
subgroups in an approximately similar ratio irrespective of the population group 
represented. Concerning the different Ig classes and subclasses, the present 
study shows a distribution for VH subgroups within IgG which was very similar 
to  the  total  distribution for total  Ig.  Some suggestive differences from this 
distribution were seen within the IgG subclasses,  particularly in IgG3  with 
somewhat high percentages for V~II and in IgG2 with higher VHI. For IgA there 
was some predominance of VHIII but not as pronounced as that which has been 
described by other workers using chemical typing (11). IgM showed slightly 
more VHI and less VHII than the average for Ig.  In addition to the two IgD 
myelomas studied another IgD protein has been partially sequenced and ap- 
pears to be VHIII (26). Thus all three IgD proteins studied so far are VHIII. 
Further studies are required to establish statistical significance for any of these 
possible associations. At any rate the present study provides further evidence 
that all Ig classes and subclasses do utilize the same VH gene pool to code for the 
V. polypeptides. 
The  serological typing systems have  several  specific  advantages in  their 
applicability. They can be used to type large panels of proteins such as those 
described in this study to determine specific relationships to other markers. In 
addition, they have particular use in typing small amounts of antibodies; these 
can be accurately typed by the serological techniques (22) in situations where 
the chemical techniques cannot be used because they require larger protein 
samples. In the case of specific antibodies an association to antibody specificity 
has been demonstrated serologically in the VK system (22, 27). Limited sequence 
studies have indicated a restriction of certain antibody population to given V 
subgroups (28, 29). The present serological typing procedure should aid consider- 
ably in  verifying and  extending these  associations.  Finally,  the  serological 
typing system also has applicability in determining VH subgroups in cell mem- 
branes, as for example in distinguishing the membrane Ig of B lymphocytes. Of 
special significance is the possibility for studying the T-cell receptor. Recent 904  DETECTION  OF  VARIABLE  REGION  SUBGROUPS  OF  Ig  HEAVY  CHAINS 
evidence  (reviewed in reference 30)  from idiotypic analyses suggests that V 
regions  of H  chains  are  involved.  If this  is  indeed  the  case,  the  subgroup 
antigens described in this study also should be present because they are deter- 
mined by the framework amino acid residues intimately involved in the idi- 
otypic antigenic sites. Such studies are currently in progress. 
Summary 
Serological test systems were established for determining the heavy-chain 
variable  region  (VH) subgroups  of immunoglobulin heavy chains.  Myeloma 
proteins with known VH subgroups based on amino acid sequence were utilized 
as the primary basis of reference for analysis by hemagglutination and hemag- 
glutination inhibition. Good agreement between the chemical and serological 
typing was obtained and nonoverlapping systems established for the three major 
VH  subgroups.  In  a  survey  of 167  myeloma proteins,  all  except  two  were 
exclusively positive  in  one  of the  three  systems.  The  two  exceptions  may 
represent a  fourth subgroup. There was an overall incidence ratio of 1:2:3 for 
VHI:VHII:VHIII subgroups. Some differences in the overall ratios were encoun- 
tered within the immunoglobulin classes. Certain advantages of the serological 
typing antisera were discussed with special emphasis on their use for studies of 
Vn antigens on the membranes of lymphocytes. 
Received for publication 16 June 1976. 
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